Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wartner is a leading global consumer healthcare brand specializing in over-the-counter treatments for warts, verrucas, and other common skin conditions. The brand achieved prominence by introducing the first cryotherapy treatment available for home use, utilizing a specialized aerosol system to mimic the liquid nitrogen freezing method used by medical professionals. Beyond cryotherapy, the Wartner portfolio includes acid-based treatments such as Trichloroacetic acid (TCA) gels delivered via precision pens for targeted application. Originally developed by Wartner Medical Products in the Netherlands, the brand was acquired by Omega Pharma, which subsequently became part of Perrigo Company plc. Wartner products are widely distributed across European pharmacies and international markets, maintaining a position as a top-selling brand in the dermatology segment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wartner Europe.